ACADIA PHARMACEUTICALS INC financial data

Symbol
ACAD on Nasdaq
Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 278% % 25%
Quick Ratio 30% % 34%
Debt-to-equity 51% % -33%
Return On Equity 32% % 25%
Return On Assets 21% % 46%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 169,181,817 shares 1.7%
Common Stock, Shares, Outstanding 169,146,043 shares 1.7%
Entity Public Float $2,000,000,000 USD -31%
Common Stock, Value, Issued $16,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 168,836,000 shares 1.7%
Weighted Average Number of Shares Outstanding, Diluted 170,650,000 shares 2.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $1,047,118,000 USD 13%
Research and Development Expense $344,776,000 USD 28%
Costs and Expenses $806,195,000 USD -1.3%
Operating Income (Loss) $240,923,000 USD 115%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $273,670,000 USD 100%
Income Tax Expense (Benefit) $12,496,000 USD 53%
Net Income (Loss) Attributable to Parent $261,174,000 USD 103%
Earnings Per Share, Basic 1 USD/shares 101%
Earnings Per Share, Diluted 1 USD/shares 99%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $257,996,000 USD 66%
Accounts Receivable, after Allowance for Credit Loss, Current $115,850,000 USD 18%
Inventory, Net $105,985,000 USD 22%
Assets, Current $1,076,422,000 USD 37%
Property, Plant and Equipment, Net $3,708,000 USD -7%
Operating Lease, Right-of-Use Asset $49,673,000 USD 12%
Other Assets, Noncurrent $2,994,000 USD 734%
Assets $1,330,771,000 USD 36%
Accounts Payable, Current $21,747,000 USD 14%
Employee-related Liabilities, Current $37,813,000 USD 2.1%
Accrued Liabilities, Current $334,837,000 USD 3.1%
Liabilities, Current $356,584,000 USD 3.7%
Deferred Income Tax Liabilities, Net $11,423,000 USD -7.8%
Operating Lease, Liability, Noncurrent $43,026,000 USD 6.4%
Other Liabilities, Noncurrent $13,889,000 USD -9.4%
Liabilities $413,499,000 USD 3.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax $989,000 USD 15%
Retained Earnings (Accumulated Deficit) $2,086,954,000 USD 11%
Stockholders' Equity Attributable to Parent $917,272,000 USD 59%
Liabilities and Equity $1,330,771,000 USD 36%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $20,323,000 USD -30%
Net Cash Provided by (Used in) Financing Activities $1,838,000 USD 76%
Net Cash Provided by (Used in) Investing Activities $124,049,000 USD -784%
Common Stock, Shares Authorized 225,000,000 shares 0%
Common Stock, Shares, Issued 169,146,043 shares 1.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $101,893,000 USD -733%
Deferred Tax Assets, Valuation Allowance $454,966,000 USD -5.6%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross $466,389,000 USD -5.7%
Operating Lease, Liability $54,809,000 USD 11%
Depreciation $229,000 USD -5.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $261,305,000 USD 101%
Lessee, Operating Lease, Liability, to be Paid $61,934,000 USD 9.7%
Property, Plant and Equipment, Gross $14,432,000 USD 1.9%
Operating Lease, Liability, Current $11,783,000 USD 32%
Lessee, Operating Lease, Liability, to be Paid, Year Two $11,888,000 USD 49%
Lessee, Operating Lease, Liability, to be Paid, Year One $11,912,000 USD 36%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 24%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $7,125,000 USD 0.85%
Lessee, Operating Lease, Liability, to be Paid, Year Three $11,413,000 USD 41%
Deferred Tax Assets, Operating Loss Carryforwards $117,052,000 USD -21%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $38,375,000 USD 3.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four $10,940,000 USD 31%
Operating Lease, Payments $11,495,000 USD 13%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $2,722,000 USD -49%
Deferred Tax Assets, Net of Valuation Allowance $8,700,000 USD 28%
Share-based Payment Arrangement, Expense $49,350,000 USD -34%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%